X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

LMDX

Closed

Lumiradx Ltd

0.016
0.000 (0.00%)
Last Update: 04 Apr 2024 23:00:00
Yesterday: 0.016
Day's Range: 0.0151 - 0.0282
Send
When Written:
 
0.622
LumiraDx Ltd is a medical technology company that specializes in developing and manufacturing innovative diagnostic products for healthcare providers. The company was founded in 2014 and is headquartered in London, UK, with additional offices and facilities in the US, Switzerland, and Scotland.

LumiraDx's products include point-of-care diagnostic devices, such as the LumiraDx Platform, which allows for rapid and accurate testing for a variety of conditions, including infectious diseases, cardiovascular disease, and diabetes. The company also offers a range of diagnostic tests and assays, including COVID-19 antigen tests.

LumiraDx has partnerships with several major healthcare organizations, including the Bill and Melinda Gates Foundation, the World Health Organization, and the National Health Service (NHS) in the UK. The company has received numerous awards and accolades for its innovative products and technology, including being named a finalist for the 2021 Edison Awards.

As of 2021, LumiraDx has raised over $1 billion in funding from investors, including the likes of Morningside Ventures, U.S. Boston Capital Corporation, and the Gates Foundation.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X